Redmond Asset Management’s Tabula Rasa HealthCare, Inc. Common Stock TRHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-10,592
Closed -$159K 200
2021
Q4
$159K Sell
10,592
-13
-0.1% -$237 0.04% 190
2021
Q3
$278K Buy
10,605
+739
+7% +$27.2K 0.09% 171
2021
Q2
$493K Hold
9,866
0.14% 158
2021
Q1
$454K Hold
9,866
0.14% 158
2020
Q4
$423K Hold
9,866
0.15% 151
2020
Q3
$402K Buy
9,866
+35
+0.4% +$1.74K 0.17% 133
2020
Q2
$538K Sell
9,831
-56
-0.6% -$3.2K 0.22% 126
2020
Q1
$517K Buy
9,887
+784
+9% +$42.4K 0.26% 108
2019
Q4
$443K Buy
9,103
+51
+0.6% +$2.39K 0.19% 131
2019
Q3
$497K Buy
9,052
+50
+0.6% +$2.86K 0.22% 122
2019
Q2
$449K Buy
9,002
+50
+0.6% +$2.49K 0.19% 133
2019
Q1
$505K Buy
8,952
+33
+0.4% +$1.97K 0.22% 125
2018
Q4
$569K Sell
8,919
-75
-0.8% -$5.31K 0.27% 102
2018
Q3
$730K Buy
+8,994
New +$659K 0.29% 98

Other funds holding TRHC

Redmond Asset Management's TRHC Position: Q1 2022 in Review

Redmond Asset Management sold out of Tabula Rasa HealthCare, Inc. Common Stock (TRHC) in Q1 2022, closing a stake of 10,592 shares — an estimated $159K sold.

Redmond Asset Management first reported a position in TRHC in Q3 2018 and held it in 14 quarters. The position peaked at $730K in Q3 2018. 139 funds tracked by Wall St. Rank hold TRHC as of Q1 2022.

  • Redmond Asset Management reported no remaining Tabula Rasa HealthCare, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Redmond Asset Management sold 10,592 Tabula Rasa HealthCare, Inc. Common Stock shares in Q1 2022, an estimated $159K.
  • Redmond Asset Management first reported a position in Tabula Rasa HealthCare, Inc. Common Stock in Q3 2018 and held it in 14 quarters.
  • Redmond Asset Management's Tabula Rasa HealthCare, Inc. Common Stock position peaked at $730K in Q3 2018.
  • 139 funds tracked by Wall St. Rank held Tabula Rasa HealthCare, Inc. Common Stock as of Q1 2022.

Based on Redmond Asset Management's 13F filing for Q1 2022, filed 3 May 2022.